Europe’s leading forum for crystal form development is returning to London in March 2009. Polymorphism and Crystallisation 2009 will give you critical updates on new analytical technologies, groundbreaking case studies and cutting edge scale-up strategies, enabling you to benchmark your organisations development processes.

A key focus for companies working in the industry is to not only to reduce the impurities and improve the properties of drugs for further development, but also to look at the correct analytical and characterisation techniques. Ensuring effective patent protection and patent term extension, whilst gaining increased market share in this current financial climate.


Confirmed Speakers Include:

• Professor Roger Davey, Molecular Engineering, University of Manchester
• Dr Michael Millan, Director of Pharma, Avantium
• Dr Surya Devarakonda, Associate Director, API Research and Development, Dr Reddys
• Dr Fiona Thorley, Research Director, Aptuit
• Dr Ingvar Ymén, Analytical Chemist, AstraZeneca
• Professor Leslie Leiserowitz, The Patricia Elman Bildner Professor of Solid State Chemistry, Weizmann Institute
• Dr Rolf Hilfiker, Head of Department, Solid State Development, Vice President, Solvias
• Professor William Jones, Materials Chemistry Group, University of Cambridge